Literature DB >> 15238505

Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer.

Malin Engelmark1, Anna Beskow, Jessica Magnusson, Henry Erlich, Ulf Gyllensten.   

Abstract

Cervical cancer is a multifactorial disease and infection by oncogenic human papilloma viruses represents the main environmental risk factor. Only a subset of infections becomes persistent and develops into cancer, implying that genetic susceptibility factors are needed for malignant progression. Here, we use a population-based cohort of affected sib-pairs (ASPs) to examine the role of the human leukocyte antigen (HLA) class I and class II loci in cervical cancer susceptibility. Analysis of 278 ASPs revealed significant excess genetic sharing for all three HLA class II loci studied, DPB1, DQB1 and DRB1, with the strongest evidence for DQB1 and DRB1. No evidence of excess sharing was observed for the HLA class I HLA-B and HLA-A loci. When the material was stratified on the basis of the DQB1*0602/DRB1*1501 susceptibility haplotype, carriers showed significant sharing for all loci, whereas non-carriers showed no evidence of excess genetic sharing at any of the loci. However, for the DPB1 locus there was no difference in allele frequency between carriers and non-carriers indicating that the effect seen in DPB1 is not simply due to linkage disequilibrium. Our results show that the HLA class II represents a major genetic susceptibility locus to cervical cancer in contrary to the class I that do not appear to have a significant impact on predisposition to the disease. The strongest class II effects are coming from the DQB1 and DRB1 loci, but the DPB1 locus also contributes to the susceptibility to cervical cancer. Copyright 2004 Oxford University Press

Entities:  

Mesh:

Year:  2004        PMID: 15238505     DOI: 10.1093/hmg/ddh201

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Concomitant autoimmunity in myasthenia gravis--lack of association with IgA deficiency.

Authors:  Ryan Ramanujam; Fredrik Piehl; Ritva Pirskanen; Peter K Gregersen; Lennart Hammarström
Journal:  J Neuroimmunol       Date:  2011-06-12       Impact factor: 3.478

2.  Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Authors:  Jian Ming Hu; Qi Sun; Ling Li; Chun Xia Liu; Yun Zhao Chen; Hong Zou; Li Juan Pang; Jin Zhao; Lan Yang; Yu Wen Cao; Xiao Bin Cui; Yan Qi; Wei Hua Liang; Wen Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.

Authors:  Felipe A Castro; Emma L Ivansson; Markus Schmitt; Ivana Juko-Pecirep; Lennart Kjellberg; Allan Hildesheim; Ulf B Gyllensten; Michael Pawlita
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

4.  Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Authors:  Margaret M Madeleine; Lisa G Johnson; Anajane G Smith; John A Hansen; Brenda B Nisperos; Sue Li; Lue-Ping Zhao; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

5.  Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers.

Authors:  Muneer Abbas; Linda D Bobo; Yu-Hsiang Hsieh; Noureddine Berka; Georgia Dunston; George E Bonney; Victor Apprey; Thomas C Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

6.  New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.

Authors:  Valeska B Guzman; Anatoly Yambartsev; Amador Goncalves-Primo; Ismael D C G Silva; Carmen R N Carvalho; Julisa C L Ribalta; Luiz Ricardo Goulart; Natalia Shulzhenko; Maria Gerbase-Delima; Andrey Morgun
Journal:  Hum Mol Genet       Date:  2008-03-12       Impact factor: 6.150

7.  Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis.

Authors:  Malin T Engelmark; Emma L Ivansson; Jessica J Magnusson; Inger M Gustavsson; Per-Ivan Wyöni; Max Ingman; Patrik K E Magnusson; Ulf B Gyllensten
Journal:  Hum Genet       Date:  2008-04-08       Impact factor: 4.132

8.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

9.  HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study.

Authors:  Sofía Bernal-Silva; Julio Granados; Clara Gorodezky; Carmen Aláez; Hilario Flores-Aguilar; Ricardo M Cerda-Flores; Geraldina Guerrero-González; Lezmes D Valdez-Chapa; José Morales-Casas; Juan Francisco González-Guerrero; Hugo A Barrera-Saldaña
Journal:  Infect Agent Cancer       Date:  2013-08-30       Impact factor: 2.965

10.  A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer.

Authors:  Dan Chen; Ulf Gyllensten
Journal:  Cancer Med       Date:  2014-02-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.